Showing results (1431-1440 of 1,491) with videos related to

Sort By:
Pageof 150
Hepatology (Baltimore, Md.)|August 24, 2017
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosisScott L Friedman, Vlad Ratziu, Stephen A Harrison, et al.
Molecular Metabolism|August 21, 2024
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activationHarrison T Muturi, Hilda E Ghadieh, Suman Asalla, et al.
American Journal of Human Genetics|February 1, 1996
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international studyS L Neuhausen, S Mazoyer, L Friedman, et al.
Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.
Cancer Research|August 15, 2008
Focal gains of VEGFA and molecular classification of hepatocellular carcinomaDerek Y Chiang, Augusto Villanueva, Yujin Hoshida, et al.
Addiction Science & Clinical Practice|March 16, 2024
Feasibility of precision smoking treatment in a low-income community setting: results of a pilot randomized controlled trial in The Southern Community Cohort StudyScott S Lee, Nicole Senft Everson, Maureen Sanderson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivativeGeurt Stokman, Anita M van den Hoek, Ditte Denker Thorbekk, et al.
World Journal of Virology|November 18, 2017
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial resultsKian Bichoupan, Neeta Tandon, James F Crismale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
Anti-TNFα treatment in Crohn's disease: Impact on hepatic steatosis, gut-derived hormones and metabolic statusPaul Manka, Svenja Sydor, Nishikant Wase, et al.
Plos Biology|May 24, 2016
The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS MyelinationBenjamin M Laitman, Linnéa Asp, John N Mariani, et al.
Pageof 150